Biguanide (sustained release) with myo-inositol
Myo-Inositol + Metformin SR Tablets for a PCOS-Focused PCD Franchise
MAZINC-MYO combines myo-inositol 600 mg with sustained-release metformin hydrochloride 500 mg in one bilayered tablet. Gynaecologists and endocrinologists prescribe the combination when managing insulin resistance associated with PCOS. This page sets out the composition, pack and handling points for business partners.
- Schedule G
- Bilayered sustained-release tablet
- Brand: MAZINC-MYO
For registered medical practitioners, pharmacists and trade partners. Not for patient self-medication.
Product specification
Composition, strength and pack of MAZINC-MYO
Taken from the product label data. Where the online catalogue does not list a detail, the table says so instead of guessing.
| FertiLogic brand | MAZINC-MYO |
|---|---|
| Generic name | Myo-Inositol & Metformin Hydrochloride (SR) Tablets |
| Composition | Each uncoated bilayered tablet contains: Myo-Inositol BP 600mg, Metformin Hydrochloride IP 500mg (as Sustained Release form), Excipients q.s. Colour: Titanium Dioxide IP & Sunset Yellow FCF |
| Strength | Myo-inositol 600 mg + metformin HCl 500 mg (SR) per tablet |
| Dosage form | Bilayered sustained-release tablet |
| Drug class | Biguanide (sustained release) with myo-inositol |
| Trade pack | 10 × 10 Tablets |
| Storage | Store in a cool, dry & dark place, below 25°C. Protect from direct sunlight, heat & moisture. Keep the medicine out of reach of children. Tablet should be swallowed whole and not be chewed or crushed. |
| Manufacturer | SB Lifesciences Pvt. Ltd. (A WHO-GMP Certified Company), Plot No. 45, EPIP, Phase-I, Jharmajri, Baddi, Distt. Solan (H.P.)-173205 (third-party manufacturer) |
| Dispensing status | Schedule G prescription drug — dangerous to take except under medical supervision. |
Clinical context
Where Myo-Inositol + Metformin SR fits in practice
Metformin is a biguanide that reduces hepatic glucose output and improves insulin sensitivity. Myo-inositol is an inositol isomer involved in insulin signalling. Prescribers combine the two when managing the insulin resistance seen in many women with PCOS.
The bilayered tablet holds metformin in a sustained-release layer, so it must be swallowed whole and not chewed or crushed. The pack directions say it is usually taken with food to reduce gastric upset.
PCOS management is long-term and reviewed periodically by the prescriber, who also needs to consider kidney, liver and cardiac status because the tablet contains metformin.
How it is used
Prescribed by gynaecologists and endocrinologists in the management of insulin resistance associated with PCOS. The tablet must be swallowed whole and is used only under medical supervision.
Prescribers to detail
- Gynaecologists
- Endocrinologists
- Physicians
Prescribing & regulatory notes
Dispensing, schedule and promotion rules for Myo-Inositol + Metformin SR
Dispensing status
Schedule G prescription drug — dangerous to take except under medical supervision.
Compliance note for partners
Metformin needs prescriber review of kidney, liver and cardiac status. Do not market as a weight-loss or "PCOS cure" product.
Printed cautions
Schedule G prescription drug — dangerous to take except under medical supervision. Not for self-medication. Inform the prescriber of kidney, liver or heart conditions and all concurrent medication. Keep out of reach of children.
Notes for chemists and stockists
- Schedule G: the label states it is dangerous to take except under medical supervision. Supply it as the prescriber directs and do not recommend it for self-medication.
- Remind patients to swallow the tablet whole. Breaking or crushing it defeats the sustained-release layer.
- Trade pack: 10 × 10 tablets.
This page gives product and trade information for healthcare professionals and pharmaceutical trade partners. It is not medical advice. Indications, dose and duration are decided by the treating doctor in line with the package insert.
For business partners
Why distributors stock Myo-Inositol + Metformin SR
Two prescriber specialties
Both gynaecologists and endocrinologists manage PCOS, so this one product opens conversations in two specialties in your district.
Long-term therapy
PCOS is managed over months, with periodic review, which means repeat dispensing at the chemists close to the prescribing clinics.
One tablet, two components
For prescribers who use this combination, a single bilayered tablet replaces two separate products on the prescription and on the chemist’s shelf.
Same prescribers as the fertility line
The gynaecologists who manage PCOS also prescribe the clomiphene combi pack (LOGICOVA) in the FertiLogic range, so the two are detailed together.
Franchise enquiry
Stock MAZINC-MYO in your district
Tell us your territory and licence details. The partner desk will confirm district availability and send the price list for MAZINC-MYO and the rest of the range.
- District monopoly rights — one partner per agreed territory.
- 65+ formulations across 5 therapeutic areas in gynaecology, fertility and women's health.
- Minimum order ₹10,000 to start.
- Free MR visual aids and promotional inputs for doctor detailing.
- Products made by third-party WHO-GMP certified manufacturers. Primus Pharmaceuticals Group has operated since 2010.
Prefer to talk? WhatsApp +91 91385 43009or email info@fertilogic.in.
FAQ
Myo-Inositol + Metformin SR PCD franchise: frequently asked questions
What is the composition of MAZINC-MYO?
Each uncoated bilayered tablet contains Myo-Inositol BP 600 mg and Metformin Hydrochloride IP 500 mg in sustained-release form. The trade pack is 10 × 10 tablets.
Is MAZINC-MYO Schedule G or Schedule H?
The pack carries the Schedule G line: dangerous to take except under medical supervision. It should be supplied as a prescriber directs and not used for self-medication.
Can MAZINC-MYO tablets be split or crushed?
No. Metformin is in a sustained-release layer, so the tablet must be swallowed whole. Breaking, chewing or crushing it defeats the release design.
Can myo-inositol with metformin be marketed for weight loss?
No. It is a prescription combination used under medical supervision in managing insulin resistance associated with PCOS. It must not be promoted as a weight-loss product or as a cure for PCOS.
Which specialists prescribe myo-inositol with metformin SR?
Mainly gynaecologists and endocrinologists, and physicians in some practices. They need to review kidney, liver and cardiac status before and during therapy.
How do I check whether my district is open for myo-inositol + metformin (MAZINC-MYO)?
FertiLogic offers district monopoly rights to business partners. Submit the enquiry form on this page with your state, district and drug-licence status, and the partner desk will confirm whether your territory is open and which products it covers. The minimum order to start is ₹10,000.
Questions about MAZINC-MYO?
Ask the partner desk about Myo-Inositol + Metformin SR availability in your district, the full product list and first-order terms (minimum order ₹10,000).